Davita Inc   (DVA)
Other Ticker:  
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
Price: $143.8800 $2.50 1.768%
Day's High: $144.57 Week Perf: 1.87 %
Day's Low: $ 139.25 30 Day Perf: 6.78 %
Volume (M): 1,129 52 Wk High: $ 147.93
Volume (M$): $ 162,455 52 Wk Avg: $112.06
Open: $142.04 52 Wk Low: $71.51

 Market Capitalization (Millions $) 13,028
 Shares Outstanding (Millions) 91
 Employees 69,000
 Revenues (TTM) (Millions $) 12,338
 Net Income (TTM) (Millions $) 1,092
 Cash Flow (TTM) (Millions $) 19
 Capital Exp. (TTM) (Millions $) 541

Davita Inc
DaVita is a leading provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease, or ESRD. We also provide acute inpatient dialysis services in approximately 700 hospitals and related laboratory services. Dialysis and dialysis related services account for approximately 97% of total net revenues. All other ancillary services and strategic initiatives, which currently account for approximately 3% of our consolidated revenues, relate primarily to our core business of providing renal care services.

   Company Address: 2000 16th Street Denver, 80202 CO
   Company Phone Number: 631-2100   Stock Exchange / Ticker: NYSE DVA

Customers Net Income fell by DVA's Customers Net Profit Margin fell to

-28.34 %

3.13 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
THC   -0.62%    
• View Complete Report

Davita Inc

Davita Inc Shines with a 112% Surge in Earnings Per Share: What This Means for Investors

The stock market is constantly influenced by various factors such as earnings reports, revenue growth, and profitability margins. In this article, we will analyze the latest fiscal period of Davita Inc, a prominent player in the Healthcare Facilities sector. We will delve into the interesting facts and figures that highlight the company's performance and its potential impact on the stock market.
Earnings per Share (EPS) Surge:
Davita Inc witnessed a remarkable 112% increase in earnings per share for the most recent fiscal period. This surge amounted to $2.65 per share compared to $1.25 per share in the corresponding period a year prior. Furthermore, in comparison to the previous reporting period, EPS soared by 64.57%, reaching $1.61 per share. Such significant growth in EPS showcases Davita's strong financial standing, which could potentially attract investors.

Davita Inc

Davita Inc. Crushes Expectations with 112.83% Surge in Profits for Q4 2023

Davita Inc. (DVA) has recently reported its financial results for the fourth quarter of 2023, showing an increase in revenue and earnings compared to the previous year. However, a deeper look into the numbers reveals that DVA may not be performing as well as its competitors in the Healthcare Facilities sector.
While revenue increased by 7.846% to $3.15 billion in the most recent fiscal period, DVA's revenue growth lags behind the 21.10% increase reported by its competitors. This underperformance suggests that DVA may be losing market share or facing challenges in growing its business.

Davita Inc

Healthcare Facilities Company Sees Astounding 131.86% Surge in Profits: Impressive Financial Performance Stuns Investors

The stock market has been buzzing with excitement lately, especially when it comes to Davita Inc. This healthcare facilities company has been making waves with its recent financial performance, and investors are taking notice.
One of the most impressive aspects of Davita Inc's recent earnings report is the significant improvement in its income per share. Compared to last year, the company's income per share has skyrocketed by a remarkable 131.86%, reaching $2.62 per share. In addition, profits have grown by an impressive 37.17% from the preceding quarter, coming in at $1.91 per share.

Davita Inc

Davita Inc Marks 2.515% Revenue Growth Amidst Sharp 16.96% Earnings Decline in Q2 2023

Davita Inc, a prominent player in the Healthcare Facilities industry, recently reported its financial results for the second quarter of 2023. While the company witnessed a solid revenue increase of 2.515%, it was unable to prevent a significant decline in income of -16.96% compared to the same reporting period a year ago. In this article, we delve into the financial figures, analyze the reasons behind the negative income trend, and provide insights into the overall performance of Davita Inc.
Financial Results and Key Statistics:
In the second quarter of 2023, Davita Inc reported revenues of $3.00 billion, representing a 2.515% growth compared to the previous year. However, this positive performance did not translate into increased income, as the company saw a significant reduction of -16.96% in this key metric. Earnings per share (EPS) for the quarter stood at $1.91.

Davita Inc

Davita Inc's Adaptive Strategies Drive Revenue Growth in Face of Declining Earnings in Q1 2023

Davita Inc may have experienced a decline in income for the first quarter of 2023, but there is reason to be optimistic about the company's future. Despite revenue only improving by 1.957%, the company has demonstrated its ability to adapt and make changes to improve its sales.
Despite the decrease in bottom-line by -17.04% from the corresponding period a year before, growth in Income per Share by 65.21% from $0.76 per share and revenue only declining by -1.515% from $2.92 billion, still shows the company is making positive strides.


Davita Inc's Segments
Dialysis & related lab services
 Segment     of total Revenue
Ancillary services & strategic initiatives
 Segment     of total Revenue
 Segment     of total Revenue
• View Complete Report

Davita Inc's Operating Statistics Decrease / Increase
Number of Treatments (thousands)   Number of Treatments (thousands) Decline   
Number of treatment days   Number of treatment days Decline   
Treatments per day (thousands)   Treatments per day (thousands) Decline   
Dialysis revenue per treatment ($)   Dialysis revenue per treatment ($) Decline   


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com